Humacyte, Inc. — Form D/A

Humacyte, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2015-01-20. The offering totals $73.8M, of which $49.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Robert E AndersonDirectorMorrisville, NC
Max W WallaceDirectorMorrisville, NC
Ted S LithgowExecutive OfficerMorrisville, NC
Robert AndersonDirectorVANCOUVER, A1
Carrie S CoxDirectorGaithersburg, MD
Carrie S CoxExecutive OfficerGaithersburg, MD
Robert S LangerDirectorNewton, MA
Dale A SanderDirectorValencia, CA
Jeffrey H LawsonExecutive OfficerDurham, NC
Paul A BoyerExecutive OfficerDurham, NC
Theodore D LithgowExecutive OfficerDurham, NC
William H TenteExecutive OfficerDurham, NC
Brady W DouganDirectorDurham, NC
Kathleen A SebeliusDirectorDurham, NC
Laura E NiklasonDirectorDurham, NC
Laura E NiklasonExecutive OfficerDurham, NC
Max N WallaceDirectorDurham, NC
Robert W LangerDirectorDurham, NC
Max A WallaceDirectorDurham, NC
Laura W NiklasonDirectorDurham, NC
Theodore S LithgowExecutive OfficerDurham, NC
Paul S BoyerExecutive OfficerMorrisville, NC
Brady E DouganDirectorDurham, NC
Max E WallaceDirectorDurham, NC
Robert E LangerDirectorDurham, NC

Other filings by this issuer (6)

FiledFormOfferingSold
2018-06-26D$150.0M$150.0M
2018-03-09D$75.0M$75.0M
2014-01-21D/A$49.1M$37.3M
2012-04-09D/A$27.0M$22.0M
2010-09-02D/A$12.0M$12.0M
2009-11-23D/A$7.0M$7.0M

More